Together with the existing Vericheck ddPCR Empty-Full Capsid Kits for serotypes AAV5 and AAV9, the addition of the new kits for serotypes AAV2 and AAV8 extends the range’s suitability to approximately ...

Adeno-associated virus (AAV) vectors have become widely recognized as a fundamental tool in gene therapy, primarily due to their potential as a delivery system for the treatment of genetic disorders.

Range of Methods Used in Generating and Purifying AAV Vectors Vectors derived from adeno-associated virus (AAV) provide promising gene delivery vehicles that can be used effectively in large-scale ...

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf Rep/Cap plasmid offering, designed to streamline ...

Thesis/Dissertation Title: Analytical Methods to Characterize Adeno-Associated Virus (AAV) Serotypes: Assessing Viral Load, Surface Charge Properties, Post-Translational Modifications, and Their ...

The "Adeno-Associated Virus (AAV) Vectors in Gene Therapy – Epidemiology Insight – 2030" report has been added to ResearchAndMarkets.com’s offering. This ‘Adeno-Associated Virus (AAV) Vector Based ...

Adeno-associated viruses (AAVs) have transformed the landscape of gene therapy product development. In the past, allocating precious samples for aggregate testing was completely impractical given the ...

Gene therapy can target the underlying causes of disease and even cure previously untreatable conditions. But despite this potential, the market remains small with only a handful of approved products.